Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

被引：0
|
作者：
Makoto Araie
Kazuhisa Sugiyama
Kenji Aso
Koji Kanemoto
Kalyani Kothapalli
Casey Kopczynski
Michelle Senchyna
David A. Hollander
机构：
[1] Kanto Central Hospital of the Mutual Aid Association of Public School Teachers,Department of Ophthalmology
[2] Kanazawa University Graduate School of Medical Science,undefined
[3] Aerie Pharmaceuticals Ireland Ltd. (Japan Branch),undefined
[4] Statistics and Data Corporation,undefined
[5] Aerie Pharmaceuticals,undefined
[6] Inc.,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Conjunctival hyperemia; Glaucoma; Intraocular pressure; Netarsudil; Rho-associated protein kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1757 / 1775
页数：18
相关论文
共 50 条
  • [31] Quality of Life and Primary Open-Angle Glaucoma in the Ocular Hypertension Treatment Study
    Gordon, Mae O.
    Gao, Feng
    Burkland, John
    Huecker, Julia B.
    Gardiner, Stuart K.
    Ramulu, Pradeep
    Zangwill, Linda M.
    Heuer, Dale K.
    Higginbotham, Eve J.
    Parrish, Richard K.
    Kass, Michael A.
    JAMA OPHTHALMOLOGY, 2024, 142 (10) : 935 - 942
  • [32] Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
    Fingeret, Murray
    Gaddie, Ian B.
    Bloomenstein, Marc
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2019, 102 (06) : 541 - 550
  • [33] Clinical characteristics of Latinos with open-angle glaucoma and ocular hypertension
    Pena, FY
    Lai, MY
    Francis, BA
    Nguyen, BB
    Deneen, J
    Wilson, MR
    Azen, SP
    Varma, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U453 - U453
  • [34] The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt®) as a primary therapy in patients with open-angle glaucoma or ocular hypertension
    Sall, K
    SURVEY OF OPHTHALMOLOGY, 2000, 44 : S155 - S162
  • [35] Pulsatile ocular blood flow in primary open-angle glaucoma and ocular hypertension
    Kerr, A
    Nelson, P
    O'brien, C
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (06) : 1106 - 1113
  • [36] Factors Influencing the Placebo Effect in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: An Analysis of Two Randomized Clinical Trials
    Kawamura, Taichi
    Sato, Izumi
    Kawakami, Koji
    PLOS ONE, 2016, 11 (06):
  • [37] OCULAR HYPERTENSION OR EARLY GLAUCOMA - OCULAR HYPERTENSION VS OPEN-ANGLE GLAUCOMA
    CHANDLER, PA
    GRANT, WM
    ARCHIVES OF OPHTHALMOLOGY, 1977, 95 (04) : 585 - 586
  • [38] Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial
    Bacharach, Jason
    Ahmed, Iqbal Ike K.
    Sharpe, Elizabeth
    Korenfeld, Michael S.
    Zhang, Steven
    Baudouin, Christophe
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 2575 - 2588
  • [39] Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
    Sarkisian Jr, Steven R.
    Ang, Robert E.
    Lee, Andy M.
    Berdahl, John P.
    Heersink, Sebastian B.
    Burden, James H.
    Doan, Long, V
    Stephens, Kerry G.
    Kothe, Angela C.
    Usner, Dale W.
    Katz, L. Jay
    Navratil, Tomas
    OPHTHALMOLOGY, 2024, 131 (09) : 1021 - 1032
  • [40] Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension
    Franks, Wendy
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (09) : 1643 - 1649
12345